Dominick Colangelo
About Dominick Colangelo
Dominick Colangelo's Current Role at Vericel
Dominick Colangelo serves as the President and CEO of Vericel. He joined the company in 2013, bringing extensive experience from his previous roles in the biopharmaceutical industry. Vericel is known for its focus on advanced cell therapies, and under Colangelo's leadership, the company aims to enhance its position in the market.
Dominick Colangelo's Experience in the Biopharmaceutical Industry
Dominick Colangelo has over twenty years of executive management and corporate development experience in the biopharmaceutical industry. His career spans significant positions in leading companies, contributing to his expertise in corporate strategy and development.
Dominick Colangelo's Tenure at Eli Lilly and Company
Dominick Colangelo spent nearly a decade at Eli Lilly and Company, where he held pivotal roles including Director of Strategy and Business Development for the Diabetes Product Group. He was also a founding Managing Director of Lilly Ventures, contributing to strategic initiatives and business development for the company.
Dominick Colangelo's Educational Background
Dominick Colangelo received a B.S.B.A. in Accounting, Magna Cum Laude, from the State University of New York at Buffalo. He furthered his education by earning a J.D. degree, with Honors, from the Duke University School of Law. His academic credentials support his extensive knowledge and capabilities in both business and law.